$Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists$

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists

Heart failure (HF) is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. American College of Cardiology Foundation / American Heart Association 2013 guidelines have classified HF into two categories: (i) HF with reduced...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Ajmer Singh, Yatin Mehta
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Wolters Kluwer Medknow Publications 2018-01-01
Σειρά:	Journal of Anaesthesiology Clinical Pharmacology
Θέματα:	Diastolic dysfunction diastolic heart failure heart failure preserved ejection fraction
Διαθέσιμο Online:	http://www.joacp.org/article.asp?issn=0970-9185;year=2018;volume=34;issue=2;spage=161;epage=165;aulast=Singh

Παρόμοια τεκμήρια

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
ανά: Dzhioeva O, κ.ά.
Έκδοση: (2020-08-01)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
ανά: M. A. Manukyan, κ.ά.
Έκδοση: (2021-11-01)

Incidence of heart failure with preserved ejection fraction (HFpEF) in COPD patients during acute exacerbation in Ain Shams University Hospitals
ανά: Hossam H Sayed, κ.ά.
Έκδοση: (2024-01-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report
ανά: Amanda Halimi, κ.ά.
Έκδοση: (2021-09-01)

The relationship between ambulatory arterial stiffness index and left ventricular diastolic dysfunction in HFpEF: a prospective observational study
ανά: Hanwen Zhang, κ.ά.
Έκδοση: (2022-06-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
ανά: Barry A. Borlaug, MD, κ.ά.
Έκδοση: (2016-01-01)

ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction
ανά: Antje Schauer, κ.ά.
Έκδοση: (2020-10-01)

Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
ανά: Abraham Abernethy, κ.ά.
Έκδοση: (2018-04-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): Part 3 Devices Based Treatment and Commentary
ανά: Soneil Guptha , Eteri Tsetskhladze
Έκδοση: (2024-08-01)

Enhanced central sympathetic tone induces heart failure with preserved ejection fraction (HFpEF) in rats
ανά: Shyam S. Nandi, κ.ά.
Έκδοση: (2023-12-01)

Do we need a definition of acute heart failure with preserved ejection fraction?
ανά: Agnieszka Kapłon-Cieślicka, κ.ά.
Έκδοση: (2021-01-01)

Similarities and Differences Between HFmrEF and HFpEF
ανά: Peixin Li, κ.ά.
Έκδοση: (2021-09-01)

Webtool to enhance the accuracy of diagnostic algorithms for HFpEF: a prospective cross‐over study
ανά: Jerremy Weerts, κ.ά.
Έκδοση: (2023-12-01)

Left atrial conduit flow rate at baseline and during exercise: an index of impaired relaxation in HFpEF patients
ανά: Paolo N. Marino, κ.ά.
Έκδοση: (2021-10-01)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
ανά: María Valero-Muñoz, κ.ά.
Έκδοση: (2022-08-01)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
ανά: Domenico D’Amario, κ.ά.
Έκδοση: (2019-11-01)

Linking abnormal fat distribution with HFpEF and diastolic dysfunction: a systematic review, meta-analysis, and meta-regression of observational studies
ανά: Zhenyue Fu, κ.ά.
Έκδοση: (2024-08-01)

Heart Failure and Aortic Stiffening in Patients with Preserved Ejection Fraction
ανά: Barış Şensoy, κ.ά.
Έκδοση: (2021-07-01)

The role of the diastolic stress echocardiographic test in the diagnosis of heart failure with preserved left ventricular ejection fraction
ανά: Bošković Nikola, κ.ά.
Έκδοση: (2023-01-01)

Predictors and Mortality for Worsening Left Ventricular Ejection Fraction in Patients With HFpEF
ανά: Liling Chen, κ.ά.
Έκδοση: (2022-02-01)

Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril Mechanics
ανά: Axel J. Fenwick, κ.ά.
Έκδοση: (2024-01-01)

Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding
ανά: Steven J. Simmonds, κ.ά.
Έκδοση: (2020-01-01)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
ανά: Maryam Ajmal, κ.ά.
Έκδοση: (2021-08-01)

Effect of empagliflozin on the left ventricular diastolic function in patients with type 2 diabetes mellitus and concomitant heart failure with preserved ejection fraction
ανά: A.S. Herashchenko, κ.ά.
Έκδοση: (2023-09-01)

Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction
ανά: Jun Gu, κ.ά.
Έκδοση: (2022-09-01)

Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
ανά: Evgeny Belyavskiy, κ.ά.
Έκδοση: (2020-09-01)

Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directions
ανά: A. M. L. N. van Ommen, κ.ά.
Έκδοση: (2022-12-01)

Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction
ανά: A. N. Kaburova, κ.ά.
Έκδοση: (2021-07-01)

Pediatric heart failure with preserved ejection fraction, a review
ανά: Sophie Quennelle, κ.ά.
Έκδοση: (2023-08-01)

Verification of haemoglobin level to prevent worsening of prognosis in heart failure with preserved ejection fraction patients from the PURSUIT‐HFpEF registry
ανά: Takashi Kitao, κ.ά.
Έκδοση: (2024-10-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): Part 1 Review of Experience and Evidence in PARAGON-HF with Commentary
ανά: Soneil Guptha; Eteri Tsetskhladze
Έκδοση: (2023-07-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): Part 2 Review of Experience and Evidence with SGLT-2 Inhibitors and Commentary
ανά: Soneil Guptha, Eteri Tsetskhladze
Έκδοση: (2023-06-01)

To determine the correlation between echocardiographic diastolic parameters and invasively measured left ventricular end diastolic pressure in patients with heart failure with preserved ejection fraction- an observational, descriptive study. (CEAL-HFpEF study)
ανά: Awadhesh kumar Sharma, κ.ά.
Έκδοση: (2021-07-01)

The Insight into the Role of Leptin and Its Receptor in Heart Failure with Preserved Ejection Fraction
ανά: Krystyna Zabojska, κ.ά.
Έκδοση: (2024-12-01)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
ανά: Artem Ovchinnikov, κ.ά.
Έκδοση: (2022-08-01)

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
ανά: Olivier Huttin, κ.ά.
Έκδοση: (2021-06-01)

Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension
ανά: Justin H. Berger, κ.ά.
Έκδοση: (2025-01-01)

Left atrial stiffness index in the identification of heart failure with preserved ejection fraction
ανά: N. E. Shirokov, κ.ά.
Έκδοση: (2024-05-01)

Vascular dysfunction in HFpEF: Potential role in the development, maintenance, and progression of the disease
ανά: Andrea Saavedra-Alvarez, κ.ά.
Έκδοση: (2022-12-01)

Association of mild kidney dysfunction with diastolic dysfunction and heart failure with preserved ejection fraction
ανά: Robin W. M. Vernooij, κ.ά.
Έκδοση: (2024-02-01)